BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

971 related articles for article (PubMed ID: 24438970)

  • 41. Mogamulizumab-induced interface dermatitis drug rash treated successfully with methotrexate and extracorporeal photopheresis in a patient with Sézary syndrome.
    Breen ID; Brumfiel CM; Patel MH; Rosenthal AC; Rule WG; DiCaudo DJ; Craig FE; Pittelkow MR; Mangold AR
    JAAD Case Rep; 2021 Mar; 9():24-27. PubMed ID: 33604439
    [No Abstract]   [Full Text] [Related]  

  • 42. First treatment of mycosis fungoides by total skin electron beam (TSEB) therapy in Greece.
    Diamantopoulos S; Platoni K; Kouloulias V; Pantelakos P; Dilvoi M; Papadavid E; Antoniou C; Efstathopoulos E
    Rep Pract Oncol Radiother; 2014 Mar; 19(2):114-9. PubMed ID: 24936330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estimation of the tissue and serum levels of IL-35 in Mycosis fungoides: a case-control study.
    Elmasry MF; Obaid YA; El-Samanoudy SI; Nour ZA; Doss SS
    Arch Dermatol Res; 2024 Jun; 316(7):349. PubMed ID: 38850434
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic Radiation Dermatitis Secondary to Narrow-Band Ultraviolet B Therapy in a Patient With Primary Cutaneous CD8 + T-Cell Lymphoma With Cytotoxic Granules.
    Edelson MP; Gay JJ; Thiel RW; Grider DJ
    Am J Dermatopathol; 2024 May; 46(5):312-315. PubMed ID: 38513130
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells.
    Amatore F; Ortonne N; Lopez M; Orlanducci F; Castellano R; Ingen-Housz-Oro S; De Croos A; Salvado C; Gorvel L; Goubard A; Collette Y; Bouabdallah R; Schiano JM; Bonnet N; Grob JJ; Gaulard P; Bagot M; Bensussan A; Berbis P; Olive D
    Blood Adv; 2020 Oct; 4(20):5203-5214. PubMed ID: 33095875
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vitamin D in Cutaneous T-Cell Lymphoma.
    Ødum AF; Geisler C
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534347
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulation of the skin microbiome in cutaneous T-cell lymphoma delays tumour growth and increases survival in the murine EL4 model.
    Dey S; Vieyra-Garcia PA; Joshi AA; Trajanoski S; Wolf P
    Front Immunol; 2024; 15():1255859. PubMed ID: 38646524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluating Response Trends of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: Analysis of Individual Patient Data From a Randomized Controlled Phase II Study to Facilitate Optimal Treatment Experiences.
    Geskin LJ; Angello JT; Bagot M; Guenova E; Nikbakht N; Querfeld C; Scarisbrick JJ
    Clin Lymphoma Myeloma Leuk; 2024 Jan; 24(1):40-47. PubMed ID: 37802679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indications.
    Mazzeo E; Rubino L; Buglione M; Antognoni P; Magrini SM; Bertoni F; Parmiggiani M; Barbieri P; Bertoni F
    Rep Pract Oncol Radiother; 2014 Mar; 19(2):77-91. PubMed ID: 24936325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gelling Your Dermatology Nursing Practice: A Practical Guide for Managing the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma With Mechlorethamine Gel.
    McCann SA; Chase AB; Tawa MC
    J Dermatol Nurses Assoc; 2016 May; 8(3):180-192. PubMed ID: 28529678
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early Organ Metastasis in Granulomatous Mycosis Fungoides: A Systematic Review.
    Motamedi M; Xiao MZX; Deschenes J; Hardin J; Sterrett R; Street L; Taparia M; Mahe E; Ferrara G; Barrie JR; Gniadecki R
    Dermatology; 2024; 240(3):468-473. PubMed ID: 38422999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature.
    Preston JD; Jansen CS; Kosaraju S; Niyogusaba T; Zhuang TZ; Iwamoto SW; Hutto SK; Lechowicz MJ; Allen PB
    CNS Oncol; 2023 Dec; 12(4):CNS105. PubMed ID: 37877303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nasal Dysbiosis in Cutaneous T-Cell Lymphoma Is Characterized by Shifts in Relative Abundances of Non-
    Hooper MJ; LeWitt TM; Veon FL; Pang Y; Chlipala GE; Feferman L; Green SJ; Sweeney D; Bagnowski KT; Burns MB; Seed PC; Guitart J; Zhou XA
    JID Innov; 2022 Sep; 2(5):100132. PubMed ID: 36161104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in patients with leukaemic cutaneous T-cell lymphoma.
    Tsai YC; Schlaepfer T; Ignatova D; Chang YT; Valaperti A; Amarov B; Blanchard G; Pehr K; Vonow-Eisenring M; Urosevic-Maiwald M; Hoetzenecker W; Pascolo S; Iselin C; Fassnacht C; Dimitriou F; Bobrowicz M; Guenova E
    Br J Dermatol; 2023 Oct; 189(5):603-611. PubMed ID: 37409661
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Impact of Primary Tumor Site on Survival in Mycosis Fungoides.
    Go CC; Zhong A; Linaburg T; Briceño CA
    Cutis; 2024 Apr; 113(4):177-182. PubMed ID: 38820109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In the skin lesions of patients with mycosis fungoides, the number of MRGPRX2-expressing cells is increased and correlates with mast cell numbers.
    Hu M; Pyatilova P; Altrichter S; Sheng C; Liu N; Terhorst-Molawi D; Lohse K; Ginter K; Puhl V; Maurer M; Metz M; Kolkhir P
    Front Immunol; 2023; 14():1197821. PubMed ID: 38022672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survival Outcomes of Patients with Mycosis Fungoides Involving the External Ear and Ear Canal.
    Wilkinson AJ; Nader ME; Roberts D; Duvic M; Gunther JR; Dabaja BS; Gidley PW
    Laryngoscope; 2023 Jun; 133(6):1486-1491. PubMed ID: 36054317
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sezary Syndrome: A Case Report and Review of Current Therapeutics.
    Krishnan J; Thanikachalam K
    Cureus; 2024 Apr; 16(4):e58570. PubMed ID: 38765439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL) epidemiology and treatment pathway in Spain: new insights for an accurate description.
    D'Agostino P; Kent A; Sharp E; Schmidt F; Turini M
    Drugs Context; 2020; 9():. PubMed ID: 32821261
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome.
    Vadivel CK; Willerslev-Olsen A; Namini MRJ; Zeng Z; Yan L; Danielsen M; Gluud M; Pallesen EMH; Wojewoda K; Osmancevic A; Hedebo S; Chang YT; Lindahl LM; Koralov SB; Geskin LJ; Bates SE; Iversen L; Litman T; Bech R; Wobser M; Guenova E; Kamstrup MR; Ødum N; Buus TB
    Blood; 2024 Apr; 143(15):1496-1512. PubMed ID: 38170178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.